logo-loader

Quotient slumps after pricing stock offering

Last updated: 17:13 05 Feb 2016 GMT, First published: 12:13 05 Feb 2016 GMT

ANGLEplc
The issue has been underwritten

Shares in Quotient (NASDAQ:QTNT) were marked sharply lower on Friday morning, tumbling to $2.69 to $7.61 after the medical diagnostics company announced a fund-raising.

The company intends to offer 4.44mln shares at $9 a share to raise $36.9mln. It has also granted the underwriter an option to purchase up to an additional 666,666 ordinary shares.

Quotient is a commercial-stage diagnostics company committed to reducing healthcare costs and improving patient care through the provision of innovative tests within established markets.

With an initial focus on blood grouping and donor disease screening, Quotient is developing its proprietary MosaiQ technology platform to offer a breadth of tests that is unmatched by existing commercially available transfusion diagnostic instrument platforms.

The company's operations are based in Scotland's capital city, Edinburgh, as well as in Eysins, Switzerland and Newtown, Pennsylvania.

The shares have traded as high as $19.95 in the last 52 weeks but have halved in the year to date following Friday's morning's 17% fall.

 

 

Oriole Resources outlines 2023 achievements and future exploration plans

Oriole Resources PLC (AIM:ORR) CEO Tim Livesey and chief financial officer Bob Smeeton join Proactive's Stephen Gunnion with details of the company's 2023 financial and operational performance. Livesey highlighted successful exploration programs in Cameroon, at the Bibemi and Mbe projects,...

27 minutes ago